Diagnostic Accuracy By Providers Study
DAP
1 other identifier
observational
299
1 country
1
Brief Summary
The validation study is intended to provide comparative data on the diagnosis of vaginal infections as performed in primary care settings versus the diagnosis provided through standard diagnostic testing performed in a reference laboratory. The clinician and lab diagnoses will be compared to those obtained using the BD MAX Vaginal Panel on the BD MAX System.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jul 2017
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 10, 2017
CompletedFirst Posted
Study publicly available on registry
May 12, 2017
CompletedStudy Start
First participant enrolled
July 6, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 15, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
August 15, 2018
CompletedOctober 4, 2018
October 1, 2018
1.1 years
May 10, 2017
October 3, 2018
Conditions
Outcome Measures
Primary Outcomes (3)
BV Result Agreement
Comparison of the level of agreement of clinician diagnosed BV to vaginal swab samples evaluated for BV using Nugent's criteria and the BD MAX Vaginal Panel
enrollment
Trichomonas (TV) Result Agreement
Comparison of the level of agreement of clinician diagnosed TV to the laboratory diagnosis of TV identified by quantitative PCR using the GeneXpert system by Cepheid and the BD MAX Vaginal Panel
enrollment
Yeast Result Agreement
Comparison of the level of agreement of clinician diagnosed yeast vaginitis to laboratory diagnosis of yeast identified with culture and the BD MAX Vaginal Panel
enrollment
Secondary Outcomes (2)
Patterns of clinician testing
enrollment
Prescribed Treatments
enrollment
Study Arms (1)
women presenting with vaginitis symptoms
Women with vaginitis seeking routine care will be approached to have five additional swabs collected during their pelvic exam * vaginal swab for qualitative PCR using the BD Max Vaginal Panel on the automated BDMAX System * Vaginal smear for evaluation with Gram's stain and Nuget's criteria * Vaginal swab for yeast culture * Vaginal swab for Trichomonas vaginalis NAAT * Vaginal swab for discrepant analysis testing
Interventions
The tests will be used to compare results between clinician diagnosis/routine care testing and the above interventions
Eligibility Criteria
Women presenting to primary care offices with symptoms of vaginitis
You may qualify if:
- Female, Age 18-40
- Presenting with symptoms of vaginitis; vaginal discharge, vaginal odor, vulvar or vaginal itch, vulvar or vaginal discomfort (i.e. irritation, burning pain or vulvar edema).
- Able and willing to provide verbal consent.
- Willingness to undergo all study-related assessments and procedures, including the collection of multiple vaginal swabs, answer questions related to demographic and health information and follow all other study-related procedures.
You may not qualify if:
- Women who meet any of the following criteria by participant report will be excluded from the study:
- ) Any condition that, in the opinion of the Investigator, would preclude provision of consent, make participation in the study unsafe, complicate interpretation of study outcome data, or otherwise interfere with achieving the study objectives.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Pittsburghlead
- Becton Dickinson Life Sciencescollaborator
Study Sites (1)
Magee-Womens Hospital of UPMC/associated community clinics
Pittsburgh, Pennsylvania, 15213, United States
Related Publications (1)
Hillier SL, Austin M, Macio I, Meyn LA, Badway D, Beigi R. Diagnosis and Treatment of Vaginal Discharge Syndromes in Community Practice Settings. Clin Infect Dis. 2021 May 4;72(9):1538-1543. doi: 10.1093/cid/ciaa260.
PMID: 32350529DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Sharon L Hillier, PhD
University of Pittsburgh
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
May 10, 2017
First Posted
May 12, 2017
Study Start
July 6, 2017
Primary Completion
August 15, 2018
Study Completion
August 15, 2018
Last Updated
October 4, 2018
Record last verified: 2018-10
Data Sharing
- IPD Sharing
- Will not share